Volume 95, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Chloroquine (CQ) remains the first-line treatment of malaria in Haiti. Given the challenges of conducting in vivo drug efficacy trials in low-endemic settings like Haiti, molecular surveillance for drug resistance markers is a reasonable approach for detecting resistant parasites. In this study, 349 blood spots were collected from suspected malaria cases in areas in and around Port-au-Prince from March to July 2010. Among them, 121 samples that were positive by polymerase chain reaction were genotyped for drug-resistant , , , and alleles. Among the 108 samples that were successfully sequenced for CQ resistant markers in , 107 were wild type (CVMNK), whereas one sample carried a CQ-resistant allele (CVIET). Neutral microsatellite genotyping revealed that the CQ-resistant isolate was distinct from all other samples in this study. Furthermore, the remaining parasite specimens appeared to be genetically distinct from other reported Central and South American populations.


Article metrics loading...

Loading full text...

Full text loading...


Data & Media loading...

Supplementary Data

Supplementary PDF

  • Received : 16 Mar 2016
  • Accepted : 01 Jun 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error